|
IQSEC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26479945908409E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.32940358510814E-11 |
| Normal-vs-Stage2 |
4.23430000000558E-05 |
| Normal-vs-Stage3 |
5.81219961048873E-10 |
| Normal-vs-Stage4 |
1.30339999904194E-08 |
| Stage1-vs-Stage2 |
5.407800E-01 |
| Stage1-vs-Stage3 |
3.142400E-01 |
| Stage1-vs-Stage4 |
1.099630E-01 |
| Stage2-vs-Stage3 |
1.571600E-01 |
| Stage2-vs-Stage4 |
5.354300E-02 |
| Stage3-vs-Stage4 |
2.629000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62891922173003E-12 |
| Normal-vs-AfricanAmerican |
2.24599999999464E-05 |
| Normal-vs-Asian |
3.82349999999976E-05 |
| Caucasian-vs-AfricanAmerican |
6.536300E-02 |
| Caucasian-vs-Asian |
5.940000E-01 |
| AfricanAmerican-vs-Asian |
3.560800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
2.379800E-04 |
| Male-vs-Female |
8.06230000000019E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.24049999999476E-05 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.12160000176331E-08 |
| Normal-vs-Extreme_Obese |
7.438300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.524000E-01 |
| Normal_Weight-vs-Obese |
9.590600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.826800E-01 |
| Extreme_Weight-vs-Obese |
2.194300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.883040E-01 |
| Obese-vs-Extreme_Obese |
5.299000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.58868999999839E-05 |
| Normal-vs-Age(41-60Yrs) |
8.5973006491713E-11 |
| Normal-vs-Age(61-80Yrs) |
1.0598966149189E-11 |
| Normal-vs-Age(81-100Yrs) |
2.4539000054169E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.454400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.550400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.665610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.232200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.147400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.760600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
8.73280003865773E-09 |
| Normal-VS-KIRP CIMP |
1.877070E-03 |
| Normal-VS-Unclassified PRCC |
1.383240E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.465200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.305900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.183700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.806400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.997820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.131400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.39568389967826E-14 |
| Normal-vs-N1 |
8.66460014847803E-10 |
| Normal-vs-N2 |
3.684700E-03 |
| N0-vs-N1 |
5.656200E-01 |
| N0-vs-N2 |
4.369400E-01 |
| N1-vs-N2 |
6.203200E-01 |
|
|
